Skip to main content
Study

Evaluating iatrogenic prescribing: development of an oncology-focused trigger tool.

Hébert G, Netzer F, Ferrua M, et al. Evaluating iatrogenic prescribing: development of an oncology-focused trigger tool. European journal of cancer (Oxford, England : 1990). 2015;51(3):427-35. doi:10.1016/j.ejca.2014.12.002.

Save

Print

Hébert G, Netzer F, Ferrua M, et al. European journal of cancer (Oxford, England : 1990). 2015;51:427-35.
| February 25, 2015

This study describes the development and validation of an oncology trigger tool, modeled after the Institute for Healthcare Improvement's Global Trigger Tool, to capture adverse drug events during cancer care. The final tool included 22 triggers and achieved high interrater reproducibility, but had only a modest 20% positive predictive value.

Save

Print

Cite
Citation

Hébert G, Netzer F, Ferrua M, et al. Evaluating iatrogenic prescribing: development of an oncology-focused trigger tool. European journal of cancer (Oxford, England : 1990). 2015;51(3):427-35. doi:10.1016/j.ejca.2014.12.002.